Screening for cervical cancer

Annals of Internal Medicine

Volumn 156, Issue 8, 2012, Pages 604-605

  Ronco, Guglielmo ^a   Meijer, Chris J L ^b   Cuzick, Jack ^c   Giorgi Rossi, Paolo ^d   Peto, Julian ^e   Segnan, Nereo ^a   Dillner, Joakim ^f  

^a Centro di Riferimento per l'Epidemiologia e la Prevenzione   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d Agenzia di Sanita Pubblica della Regione Lazio   (Italy)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER SCREENING; CLINICAL PRACTICE; EUROPEAN UNION; FEMALE; HUMAN; LETTER; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

EID: 84859760178     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-156-8-201204170-00014     Document Type: Letter

References (7)

1. Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155:687-697, W214-5. [PMID: 22006930]
2. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008;26 Suppl 10:K29-K41. [PMID: 18847555]
3. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007;357:1589-1597. [PMID: 17942872]
4. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neo-plasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007;370:1764-1772. [PMID: 17919718]
5. Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol. 2009;10:672-682. [PMID: 19540162]
6. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al; New Technologies for Cervical Cancer screening (NTCC) Working Group. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11:249-257. [PMID: 20089449]
7. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al, eds. European Guidelines for Quality Assurance on Cervical Cancer Screening. 2nd ed. Luxembourg: Office Official Publications European Communities; 2008.